103 related articles for article (PubMed ID: 23744811)
1. Probing the dimerization interface of Leishmania infantum trypanothione reductase with site-directed mutagenesis and short peptides.
Toro MA; Sánchez-Murcia PA; Moreno D; Ruiz-Santaquiteria M; Alzate JF; Negri A; Camarasa MJ; Gago F; Velázquez S; Jiménez-Ruiz A
Chembiochem; 2013 Jul; 14(10):1212-7. PubMed ID: 23744811
[TBL] [Abstract][Full Text] [Related]
2. Modeled structure of trypanothione reductase of Leishmania infantum.
Singh BK; Sarkar N; Jagannadham MV; Dubey VK
BMB Rep; 2008 Jun; 41(6):444-7. PubMed ID: 18593527
[TBL] [Abstract][Full Text] [Related]
3. First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity
Ruiz-Santaquiteria M; Sánchez-Murcia PA; Toro MA; de Lucio H; Gutiérrez KJ; de Castro S; Carneiro FAC; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
Eur J Med Chem; 2017 Jul; 135():49-59. PubMed ID: 28431354
[TBL] [Abstract][Full Text] [Related]
4. Molecular docking studies of selected tricyclic and quinone derivatives on trypanothione reductase of Leishmania infantum.
Venkatesan SK; Shukla AK; Dubey VK
J Comput Chem; 2010 Oct; 31(13):2463-75. PubMed ID: 20340105
[TBL] [Abstract][Full Text] [Related]
5. Biophysical and folding parameters of trypanothione reductase from Leishmania infantum.
Shukla AK; Patra S; Dubey VK
Appl Biochem Biotechnol; 2011 Sep; 165(1):13-23. PubMed ID: 21445596
[TBL] [Abstract][Full Text] [Related]
6. Improved proteolytic stability and potent activity against Leishmania infantum trypanothione reductase of α/β-peptide foldamers conjugated to cell-penetrating peptides.
de Lucio H; Gamo AM; Ruiz-Santaquiteria M; de Castro S; Sánchez-Murcia PA; Toro MA; Gutiérrez KJ; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
Eur J Med Chem; 2017 Nov; 140():615-623. PubMed ID: 29017116
[TBL] [Abstract][Full Text] [Related]
7. Efficient Dimerization Disruption of
Revuelto A; de Lucio H; García-Soriano JC; Sánchez-Murcia PA; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
J Med Chem; 2021 May; 64(9):6137-6160. PubMed ID: 33945281
[TBL] [Abstract][Full Text] [Related]
8. A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.
Ilari A; Baiocco P; Messori L; Fiorillo A; Boffi A; Gramiccia M; Di Muccio T; Colotti G
Amino Acids; 2012 Feb; 42(2-3):803-11. PubMed ID: 21833767
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives.
Saccoliti F; Angiulli G; Pupo G; Pescatori L; Madia VN; Messore A; Colotti G; Fiorillo A; Scipione L; Gramiccia M; Di Muccio T; Di Santo R; Costi R; Ilari A
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):304-310. PubMed ID: 28098499
[TBL] [Abstract][Full Text] [Related]
10. Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis.
Baiocco P; Franceschini S; Ilari A; Colotti G
Protein Pept Lett; 2009; 16(2):196-200. PubMed ID: 19200044
[TBL] [Abstract][Full Text] [Related]
11. Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism.
Colotti G; Saccoliti F; Gramiccia M; Di Muccio T; Prakash J; Yadav S; Dubey VK; Vistoli G; Battista T; Mocci S; Fiorillo A; Bibi A; Madia VN; Messore A; Costi R; Di Santo R; Ilari A
Amino Acids; 2020 Feb; 52(2):247-259. PubMed ID: 31037461
[TBL] [Abstract][Full Text] [Related]
12. Leishmania infantum trypanothione reductase is a promiscuous enzyme carrying an NADPH:O2 oxidoreductase activity shared by glutathione reductase.
Angiulli G; Lantella A; Forte E; Angelucci F; Colotti G; Ilari A; Malatesta F
Biochim Biophys Acta; 2015 Sep; 1850(9):1891-7. PubMed ID: 26033467
[TBL] [Abstract][Full Text] [Related]
13. Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.
Ruiz-Santaquiteria M; de Castro S; Toro MA; de Lucio H; Gutiérrez KJ; Sánchez-Murcia PA; Jiménez MÁ; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
Eur J Med Chem; 2018 Apr; 149():238-247. PubMed ID: 29501944
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of antimony treatment in leishmaniasis.
Baiocco P; Colotti G; Franceschini S; Ilari A
J Med Chem; 2009 Apr; 52(8):2603-12. PubMed ID: 19317451
[TBL] [Abstract][Full Text] [Related]
15. Enlightening the molecular basis of trypanothione specificity in trypanosomatids: mutagenesis of Leishmania infantum glyoxalase II.
Barata L; Sousa Silva M; Schuldt L; Ferreira AE; Gomes RA; Tomás AM; Weiss MS; Ponces Freire A; Cordeiro C
Exp Parasitol; 2011 Dec; 129(4):402-8. PubMed ID: 21864532
[TBL] [Abstract][Full Text] [Related]
16. Pyrrolopyrimidine vs Imidazole-Phenyl-Thiazole Scaffolds in Nonpeptidic Dimerization Inhibitors of Leishmania infantum Trypanothione Reductase.
Revuelto A; Ruiz-Santaquiteria M; de Lucio H; Gamo A; Carriles AA; Gutiérrez KJ; Sánchez-Murcia PA; Hermoso JA; Gago F; Camarasa MJ; Jiménez-Ruiz A; Velázquez S
ACS Infect Dis; 2019 Jun; 5(6):873-891. PubMed ID: 30983322
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography.
Baiocco P; Poce G; Alfonso S; Cocozza M; Porretta GC; Colotti G; Biava M; Moraca F; Botta M; Yardley V; Fiorillo A; Lantella A; Malatesta F; Ilari A
ChemMedChem; 2013 Jul; 8(7):1175-83. PubMed ID: 23733388
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling, structural analysis and identification of ligand binding sites of trypanothione reductase from Leishmania mexicana.
Mutlu O
J Vector Borne Dis; 2013 Mar; 50(1):38-44. PubMed ID: 23703438
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression of trypanothione reductase from a New World Leishmania species.
Castro-Pinto DB; Genestra M; Menezes GB; Waghabi M; Gonçalves A; De Nigris Del Cistia C; Sant'Anna CM; Leon LL; Mendonça-Lima L
Arch Microbiol; 2008 Apr; 189(4):375-84. PubMed ID: 18060667
[TBL] [Abstract][Full Text] [Related]
20. Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor.
de Lucio H; Toro MA; Camarasa MJ; Velázquez S; Gago F; Jiménez-Ruiz A
Br J Pharmacol; 2020 Nov; 177(22):5163-5176. PubMed ID: 32888319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
